Articles
23 June 2009
Vol. 2 No. 5: New Drugs in Hematology, Bologna, Italy 5-7 October 2008
https://doi.org/10.4081/hmr.v2i5.757

Is there a role for immunotherapy in Hodgkin’s disease?

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
173
Views
568
Downloads

Authors

B Böll
support@pagepress.org
A Engert
To date, most patients with Hodgkin’s lymphoma (HL) can be cured with chemotherapy, radiotherapy or combined modality treatment. However, current treatment is associated with severe side effects and late toxicities such as infertility, cardiovascular damage and secondary malignancies. Moreover, a fraction of patients suffers from refractory disease and cannot be cured with current approaches including high dose chemotherapy and stem cell transplant.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Is there a role for immunotherapy in Hodgkin’s disease?. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(5). https://doi.org/10.4081/hmr.v2i5.757